kabutan

Medical Data Vision Co.,Ltd.(3902) Summary

3902
TSE Prime
Medical Data Vision Co.,Ltd.
1,685
JPY
+1
(+0.06%)
Apr 10, 3:30 pm JST
10.57
USD
Apr 10, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
PBR
20.7
Yield
ー%
Margin Trading Ratio
9.86
Stock Price
Apr 10, 2026
Opening Apr 10, 9:00 am
1,684 JPY 10.58 USD
Previous Close Apr 9
1,684 JPY 10.59 USD
High Apr 10, 9:50 am
1,685 JPY 10.59 USD
Low Apr 10, 9:00 am
1,684 JPY 10.56 USD
Volume
16,700
Trading Value
0.03B JPY 0.18M USD
VWAP
1684.17 JPY 10.57 USD
Minimum Trading Value
168,500 JPY 1,057 USD
Market Cap
0.07T JPY 0.42B USD
Number of Trades
70
Liquidity & Number of Trades
As of Apr 10, 2026
Liquidity
Mid
1-Year Average
354
1-Year High Dec 18, 2025
3,108
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 3, 2026 1,000 13,100 13.10
Mar 27, 2026 1,000 13,400 13.40
Mar 19, 2026 1,000 19,800 19.80
Mar 13, 2026 1,000 20,000 20.00
Mar 6, 2026 1,200 25,400 21.17
Company Profile
Medical Data Vision Co., Ltd. provides a "Data Network" for hospital and medical information, as well as data utilization services of medical information for pharmaceutical companies.
Sector
Information & Communication
Medical Data Vision Co., Ltd. offers management support systems for hospitals and clinics while simultaneously collecting and storing medical and health information with consent from medical institutions and patients. By analyzing and utilizing this data, the company contributes to improving the quality of healthcare. Their main services include "MDV Act," a cloud-based hospital management improvement application; "EVE," a DPC (Diagnosis Procedure Combination) analysis benchmark system; and "Medical Code," a management issue resolution support system. Through the provision of these systems, the company has built a hospital network, which forms the basis for constructing a large-scale medical database. Utilizing this database, Medical Data Vision offers "MDV analyzer," a drug prescription analysis tool, and ad hoc survey services for pharmaceutical companies and research institutions. Additionally, the company has developed "Karteco," a PHR (Personal Health Record) service for patients.